By Dr. Peter M. Bonutti, M.D. - Founder, UVCeed | April 2026
A wave of new UV disinfection products has hit the market in recent years, many of them built around a technology called 222nm "far-UVC" light. The marketing claims are bold: faster germ-killing, superior performance, next-generation technology. Some published studies even suggest 222nm light works better than the conventional 254-265nm UV-C wavelength that hospitals have relied on for decades.
There's just one problem. The science behind those claims has a fundamental flaw - one so basic that it calls into question the real-world effectiveness of every product built on this technology.
As an orthopedic surgeon, medical device inventor, and the founder of UVCeed, I have spent my career at the intersection of infection control and engineering. I am submitting a formal letter to the editors of several scientific journals outlining critical methodological concerns with the 222nm efficacy literature. What follows is the core of that argument - written for the people who actually need to understand it: you, the consumer trying to make an informed decision about how to protect your family.
The Claim: 222nm Far-UVC Is "Better" at Killing Germs
Proponents of 222nm technology argue that this shorter wavelength attacks pathogens through a dual mechanism - damaging both proteins and DNA simultaneously - while also being safer for human skin and eyes. Several published studies report that 222nm achieves comparable or even faster pathogen inactivation than the 254-265nm wavelength used in hospital-grade UV-C systems.
On paper, it sounds like a clear upgrade. In the real world, it falls apart.
The Problem: Germs Don't Exist the Way These Studies Assume
Here is the critical issue that the 222nm research community has not adequately addressed.
Nearly every study showing 222nm superiority was conducted on what microbiologists call "planktonic single-cell suspensions" - essentially, individual bacteria or viruses floating alone in a thin, perfectly spread layer under laboratory conditions. In this setup, every single pathogen is fully exposed to the UV light from all angles. Nothing is blocking the photons from reaching their target.
This is not how germs exist in your life. Not even close.
Over fifty years of microbiology research has established that bacteria overwhelmingly exist in clusters, clumps, and biofilms - not as isolated single cells. The published science on this point is not debatable:
- More than 99.9% of bacteria in natural environments grow in biofilms attached to surfaces
- Even "free-floating" bacteria in wounds, saliva, and respiratory droplets exist as multicellular aggregates embedded in protein-rich biological material
- Airborne pathogens travel inside droplets and aerosol particles that contain mucus, proteins, and cellular debris - not as naked, isolated organisms
This matters enormously because of a basic physics problem that 222nm technology cannot escape.
The Physics: 222nm Light Cannot Penetrate Deep Enough
The same property that makes 222nm safer for human skin is also its greatest weakness as a germicide. The 222nm wavelength is absorbed almost immediately by the first layer of protein it contacts. That is why it does not penetrate past the dead outer layer of human skin - and why it is considered safer for use around people.
But that shallow penetration is a double-edged sword. When 222nm photons hit a clump of bacteria, a biofilm on a surface, or a protein-rich respiratory droplet, the outermost layer of biological material absorbs the light before it can reach the pathogens hiding underneath. The outer cells act as a shield for the inner cells.
By contrast, the 254-265nm wavelength used in hospital-grade systems like UVCeed is not preferentially absorbed by surface proteins. It penetrates substantially deeper into biological material, reaching organisms that 222nm simply cannot touch.
The numbers make this concrete. A typical bacterium is 1-2 micrometers across. A cluster just 10 cells deep presents a biological depth of 10-20 micrometers. The effective penetration depth of 222nm light through protein-rich material is only a few micrometers. The math is straightforward: 222nm runs out of energy before it reaches the interior of even a modest bacterial aggregate.
The Published Evidence Confirms This
This is not theoretical speculation. The peer-reviewed literature already documents exactly this problem.
A 2022 study in Water Research tested UV inactivation across multiple UVC wavelengths on both planktonic bacteria and intact biofilms. The results were striking: while planktonic bacteria showed greater than 6-log reduction (99.9999% kill rate), the same organisms in biofilm form achieved only 1.5 to 2.5-log reduction - and 222nm performed no better than 254nm. In some comparisons, it performed worse.
Research on cyanobacterial aggregates produced the same finding. The aggregates showed significantly greater resistance to 222nm specifically because the outer cells and their protein-rich extracellular material absorbed the photons before they could reach interior organisms. This is exactly what physics predicts.
The Airborne Pathogen Problem
One of the most common marketing claims for 222nm technology is superior performance against airborne pathogens like SARS-CoV-2. But this claim suffers from the same fundamental flaw.
Airborne respiratory droplets are not naked, isolated virus particles floating in clean air. They are complex biological packages - mucus, protein, saliva, and cellular debris - with pathogens embedded at varying depths inside. A coronavirus particle is roughly 100 nanometers in diameter, well within the penetration range of 222nm. But the droplet nucleus carrying that virus is 1-10 micrometers across and wrapped in protein-rich material that absorbs 222nm light at the surface.
The assumption that 222nm effectively penetrates real-world aerosol particles has not been validated under realistic conditions. The studies showing impressive results used aerosolized single-organism suspensions in controlled chambers - not the biological complexity of an actual cough or sneeze.
The Conflict of Interest Problem
There is another issue that consumers and the scientific community should be aware of.
A significant portion of the published research supporting 222nm superiority originates from, or is funded by, companies that manufacture and sell 222nm lamp technology. In at least one key study published in Scientific Reports, the lead author's affiliation was the commercial sales division of the world's primary manufacturer of 222nm filtered excimer lamps - yet the paper declared no competing interests.
This does not mean all 222nm research is fraudulent. But it does mean the literature should be read with appropriate skepticism, especially when study designs consistently use the conditions most favorable to 222nm performance (dilute, well-dispersed, single-cell suspensions) rather than the conditions that reflect how germs actually exist.
What the Honest Science Actually Supports
To be clear: 222nm far-UVC is not worthless. It has a genuine safety advantage for continuous use in occupied rooms where people are present, because its shallow penetration means it does not reach living skin cells or eye tissue. That is a real benefit for certain applications.
But the honest reading of the published evidence supports a more limited set of conclusions than the marketing would suggest:
- Under idealized single-cell lab conditions, 222nm achieves comparable - not clearly superior - germ-killing efficiency to 254-265nm
- Under realistic conditions involving biofilms, aggregates, and multi-organism clusters, 222nm is likely inferior to 254-265nm due to shallower penetration
- 222nm has a legitimate human safety advantage for occupied-space deployment
- Claims of 222nm superiority that rest entirely on planktonic single-cell data should not be generalized to surface disinfection or aerosol decontamination without real-world validation
Why UVCeed Uses Hospital-Grade 265nm UV-C Technology
When we designed UVCeed, we made a deliberate engineering decision to use 265nm UV-C LED technology - the wavelength proven effective in hospital disinfection systems for decades. Here is why.
It works on real-world germs, not just lab-prepared samples. The 265nm wavelength penetrates deeper into biological material, reaching pathogens in biofilms, aggregates, and protein-rich environments that 222nm cannot effectively treat. When you disinfect your water bottle, your child's high chair, or a gym equipment handle, you are not dealing with perfectly dispersed single cells. You are dealing with the biological reality of how germs actually live - and 265nm is built for that reality.
It is backed by decades of clinical validation. Hospital-grade UV-C disinfection at this wavelength range has been studied, validated, and deployed in healthcare settings for over half a century. The evidence base is enormous and not dependent on industry-funded studies using idealized conditions.
UVCeed adds what no other device offers: verification. Our patented AI-powered system uses your smartphone camera to provide real-time visual confirmation that disinfection is actually happening. You see the surface being treated. You get guidance on proper distance, angle, and duration. You receive confirmation when 99.99% disinfection is achieved. No guessing. No hoping. Proof.
It is safe when used as directed. UVCeed's built-in safety system uses machine vision to detect the presence of humans and pets, automatically disabling UV-C output to prevent accidental exposure. The device only operates through the smartphone app, which provides continuous safety monitoring throughout the disinfection process.
The Bottom Line: Don't Buy Marketing. Buy Science.
The UV disinfection market is full of bold claims and flashy technology. But when your family's health is on the line, what matters is not which wavelength sounds more advanced - it is which one actually kills germs under the conditions where germs actually exist.
The 222nm far-UVC literature has a fundamental methodological problem that its proponents have not resolved. The planktonic single-cell assumption embedded in their efficacy data does not reflect the biological reality of how pathogens organize, and the published biofilm and aggregate data already show that 222nm's shallow penetration is a real-world limitation.
UVCeed was built on the science that works - hospital-grade 265nm UV-C, validated across decades of clinical use, enhanced with AI-powered guidance and real-time visual verification. It is the same technology trusted by healthcare facilities, now available in a device that fits in your pocket.
Don't settle for lab-only science. Get the disinfection that works in your actual life.
Shop UVCeed at uvceed.com - Use code UV15OFF for 15% off + free shipping.
About the Author
Dr. Peter M. Bonutti, M.D. is an orthopedic surgeon, medical device inventor, and founder of UVCeed and Bonutti Technologies. With over 400 patents and 30+ years of innovation in medical devices, Dr. Bonutti developed UVCeed to bring hospital-grade infection control technology to consumers. UVCeed has been recognized as one of Fast Company's Next Big Things in Tech and is currently deployed in healthcare facilities including Sarah Bush Lincoln Hospital.
UVCeed uses 265nm UV-C LED technology for surface disinfection. Results based on independent laboratory testing: 99.9% reduction of Staphylococcus aureus in 15 seconds, 99.99% reduction of E. coli in 24 seconds, and 99.9% reduction of SARS-CoV-2 in 32 seconds on hard non-porous surfaces at 12.7 cm. See uvceed.com for full testing details and disclaimers.
Want More Articles Like This?
Get research on UV-C treatment and product updates delivered to your inbox.
